Radiopharm Theranostics
$4.4
5
+$0.08+1.85% Today
Statistics
Day High
4.4
Day Low
4.16
52W High
16.25
52W Low
3.5
Volume
23,500
Avg. Volume
168,018
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
27FebExpected
Expected EPS
-0.00504507725
Actual EPS
-0.007006125
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RADX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It develops RAD 204, a programmed death-ligand 1 (PD-L1) for the treatment of non-small cell lung cancer (NSCLC); RAD 202, a human epidermal growth factor receptor 2 (HER2) to treat breast cancer and other solid tumors; and RAD 301, a diagnostic radiopharmaceutical targeting avß6 integrin in pancreatic ductal adenocarcinoma patients. The company also develops RAD 302, an avß6-integrin targeting agent for the treatment of multiple cancer types; RAD 101 and RAD 102 for brain metastases; RAD 402 to treat advanced prostate cancer; and RV01 for multiple solid tumors. It has strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia.
Show more...
CEO
Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD
Country
US
ISIN
US75041J1016
Listings
0 Comments
Share your thoughts
FAQ
What is Radiopharm Theranostics stock price today?▼
The current price of RADX is $4.4 USD — it has increased by +1.85% in the past 24 hours. Watch Radiopharm Theranostics stock price performance more closely on the chart.
What is Radiopharm Theranostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Radiopharm Theranostics stocks are traded under the ticker RADX.
Is Radiopharm Theranostics stock price growing?▼
RADX stock has risen by +3.53% compared to the previous week, the month change is a -11.11% fall, over the last year Radiopharm Theranostics has showed a -15.22% decrease.
When is the next Radiopharm Theranostics earnings date?▼
Radiopharm Theranostics is going to release the next earnings report on September 24, 2026.
What were Radiopharm Theranostics earnings last quarter?▼
RADX earnings for the last quarter are -0.01 USD per share, whereas the estimation was -0.01 USD resulting in a -38.87% surprise. The estimated earnings for the next quarter are N/A USD per share.
In which sector is Radiopharm Theranostics located?▼
Radiopharm Theranostics operates in the Health Care sector.
When did Radiopharm Theranostics complete a stock split?▼
Radiopharm Theranostics has not had any recent stock splits.
Where is Radiopharm Theranostics headquartered?▼
Radiopharm Theranostics is headquartered in Carlton, US.